Back

Optimizing antiplatelet therapy in ACS: a network meta-analysis of simplified regimens

1 September 2025 (15:18 - 15:30)
Organised by: Logo
Congress Presentation Part of: Novel antiplatelet approaches following acute coronary syndromes or percutaneous coronary intervention Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Nicolas del-Cuerpo-Salinas

UNIVERSITY HOSPITAL SAN JUAN DE ALICANTE, Sant Joan d'Alacant (Spain)

2 More presentations in this session

Presentation thumbnail
Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3
Mr Y. Obayashi (Leiden, NL)
Abstract Slides
Presentation thumbnail
Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients (LEGACY)
Miss S. Sivanesan (Amsterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Novel antiplatelet approaches following acute coronary syndromes or percutaneous coronary intervention
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 15:18 CET
You may be interested in
thumbnail
Congress Presentation
Comparative efficacy and safety of de-escalation, abbreviation, and standard potent P2Y12 inhibitor based DAPT strategies after acute coronary syndrome: a network meta analysis
thumbnail
Congress Presentation
Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3
thumbnail
Congress Presentation
Optimizing post-PCI therapy: ticagrelor, prasugrel, clopidogrel, and cilostazol reduce early MACE

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources